Abstract

<h3>In Reply.</h3> —The classification of second lymphoid neoplasms occurring in patients treated for HD is often difficult. It is for this reason that we referred to these tumors as "second lymphoid malignant neoplasms" rather than "non-Hodgkin's lymphomas." This difficulty in classification can also occur in patients seen with de novo non-Hodgkin's lymphoid neoplasms. For example, the difference between T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma is often an arbitrary distinction. Two of the patients in our series and some other previously described patients had peripheral blood involvement at the time of the diagnosis of a second lymphoid malignant neoplasm and might have been classified as having leukemia. It is likely that patients with peripheral blood involvement are more likely to be recognized than patients with only recurrent lymphadenopathy, because peripheral blood involvement would be a particularly unusual manifestation of Hodgkin's disease. Although acute lymphoblastic leukemia has been recognized in patients

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.